Cannabis-focused research and development company The Green
Organic Dutchman Holdings (TSX: TGOD) (OTC: TGODF), together with Epican
Medicinals, a company in which TGODF owns 49.18%, this morning announced the
successful opening of its first legal cannabis retail store in Jamaica on
Saturday, July 14th. Epican and TGOD will be provided with immediate revenue
from the sale of premium Jamaican grown organic cannabis at the flagship
location. The dispensary in Kingston represents the first of several Epican Herb
Houses planned to be finalized across Jamaica by the end of 2018. “The Kingston
dispensary is an important step in TGOD’s global strategy,” The Green Organic
Dutchman Holdings president Csaba Reider stated in the news release.
“Commercializing legalized, high-quality, organic medical cannabis to the
market is proof of our commitment to portfolio companies and our ability to go
beyond cash infusion. The Epican team are great business partners and we would
like to thank all those involved who have made this day happen.”
To view the full press release, visit http://ibn.fm/ZMBRK
About the Green Organic Dutchman Holdings Ltd.
The Green Organic Dutchman Holdings Ltd. is a research &
development company licensed under the Access to Cannabis for Medical Purposes
Regulations (“ACMPR”) to cultivate medical cannabis. The company carries out
its principal activities producing cannabis from its facilities in Ancaster,
Ont., pursuant to the provisions of the ACMPR and the Controlled Drugs and
Substances Act (Canada) and its regulations. The company grows high quality,
organic cannabis with sustainable, all-natural principles. TGOD’s products are
laboratory tested to ensure patients have access to a standardized, safe and
consistent product. TGOD has a funded capacity of 170,000 kg of cultivation
facilities in Ontario and Quebec and Jamaica. The company has developed a
strategic partnership with Aurora Cannabis Inc. (TSX: ACB) whereby Aurora has
invested approximately C$78.1 million for an approximate 17.5% stake in TGOD.
In addition, the company has raised approximately C$315 million dollars and has
over 20,000 shareholders. TGOD’s common shares and warrants issued under the
indenture dated November 1, 2017 trade on the TSX under the symbol “TGOD” and
“TGOD.WT”, respectively. For more information, visit the company’s website
at www.TGOD.ca
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
